Efficacy and safety of first-line bevacizumab (BEV) plus interferon-α2a (IFN) in patients (pts) ≥65 years with metastatic renal cell carcinoma (mRCC)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 5095-5095 ◽  
Author(s):  
E. Bajetta ◽  
A. Ravaud ◽  
S. Bracarda ◽  
S. Négrier ◽  
C. Szczylik ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Efficacy And Safety ◽  
First Line ◽  
Interferon Α2a

Efficacy and safety of first‐line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study

2020 ◽  
Vol 27 (12) ◽  
pp. 1095-1100 ◽  
Author(s):  
Toshikazu Tanaka ◽  
Shingo Hatakeyama ◽  
Kazuyuki Numakura ◽  
Koichi Kido ◽  
Daisuke Noro ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Retrospective Study ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Efficacy And Safety ◽  
First Line

scholarly journals Efficacy and Safety of Axitinib as First-Line Therapy in Japanese Patients with Metastatic Renal Cell Carcinoma

2015 ◽  
Vol 06 (08) ◽  
pp. 670-678 ◽  
Author(s):  
Takeshi Namekawa ◽  
Satoshi Fukasawa ◽  
Atsushi Komaru ◽  
Masayuki Kobayashi ◽  
Takayuki Ohzeki ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Efficacy and safety of first-line sunitinib in Chinese patients with metastatic renal cell carcinoma

2018 ◽  
Vol 14 (18) ◽  
pp. 1835-1845 ◽  
Author(s):  
Shu-Kui Qin ◽  
Jie Jin ◽  
Jun Guo ◽  
Jin-Wan Wang ◽  
Fang-Jian Zhou ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Chinese Patients ◽  
Efficacy And Safety ◽  
First Line
Sign in / Sign up

Export Citation Format

Share Document